title: [Treatment of advanced colorectal cancer with long-term continuous infusion of 5-fluorouracil].
abstract: The purpose of the study was to evaluate the efficacy of long-term continuous administration of 5-fluorouracil (5-FU) in ambulatory patients with colorectal cancer. Nineteen patients with advanced colorectal cancer were treated with continuous intravenous infusion of 5-FU (500 mg/day). The minimum duration of therapy was projected to be four weeks. In some patients 4 weeks interval therapy was selected and in other patients the duration of therapy was open-ended. A portable pump was used to deliver 5-FU continuously into the venous system at home. The pump had a subcutaneously placed port connected to a central venous catheter. In 19 patients, the duration of 5-FU infusion was 56 to 427 days (median: 139 days), and cumulative doses of 5-FU ranged from 28 to 173.5 g (median 69.5 g). Five patients achieved partial response (response rate: 26.3%), and the response lasted 80 to 339 days (median: 204 days). The fifty-percent survival time was 17 months. In 16 patients whose serum CEA level was elevated, there was a decrease to less than 50% among 11 patients (69%). Dose limiting toxicity was stomatitis in 4 patients and hand-foot syndrome in one, but they recovered after interruption of the infusion. Hematological toxicity was generally mild. No infusion-system related complication was encountered. Patients were able to be discharged and live at home during 82% of their survival period, while receiving this therapy. We concluded that this treatment is effective with tolerable toxicity and can be conducted at home.
authors.affiliation: Dept. of Surgery, Tochigi Cancer Center.
authors.forename: K
authors.initials: K
authors.lastname: Kotake
authors.forename: Y
authors.initials: Y
authors.lastname: Koyama
authors.forename: J
authors.initials: J
authors.lastname: Nasu
authors.forename: J
authors.initials: J
authors.lastname: Ando
authors.forename: I
authors.initials: I
authors.lastname: Ozawa
authors.forename: Y
authors.initials: Y
authors.lastname: Ogata
mesh_terms: D000368:Aged; D000553:Ambulatory Care; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D004334:Drug Administration Schedule; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage*; D006801:Humans; D007260:Infusion Pumps; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged
chemical_list: D005472:Fluorouracil